Johnson & Johnson coronavirus vaccine submitted for EU approval

Johnson & Johnson coronavirus vaccine submitted for EU approval
Credit: Belga

Belgian-based company Janssen Pharmaceutica, owned by US-based Johnson & Johnson, submitted its vaccine against the new coronavirus (Covid-19) to the European Medicines Agency (EMA) for approval on Tuesday.

The agency has confirmed it could make a decision on the vaccine, which requires just one dosis, by the middle of March.

Belgium has ordered 5 million doses of this particular vaccine, which plays a pivotal role in its vaccination strategy.

Related News

Following several trials, the efficacy rate is 66%, which is considerably lower than that of other already approved vaccines including the Pfizer/BioNTech and Moderna vaccines, which offer about 90% protection.

Instead of using RNA technology, it is a vector-based vaccine, meaning it introduces the coronavirus S protein DNA into the body based on a cold virus, causing the body to produce antibodies against the protein and eventually the virus.

Lauren Walker

The Brussels Times

804 top jobs in Belgium

Scrum MasterAtlas CopcoSales Operations AnalystBridgestoneOperational Purchaser (TEMP)ADB SafegateManager Mechanish OnderhoudAGC Glass EuropeProject Officer - Test and Evaluation(EDA) European Defence Agency

Latest News

Copyright © 2021 The Brussels Times. All Rights Reserved.